Hajime Kataoka | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hajime Kataoka | Heart Failure | Best Researcher Award

Nishida Hospital | Japan

Dr. Hajime Kataoka is a distinguished Cardiologist and Physician-Scientist at Nishida Hospital, Oita, Japan, widely recognized for his pioneering contributions to cardiovascular medicine. He has devoted his career to advancing the understanding, diagnosis, and treatment of cardiovascular diseases, with particular expertise in clinical electrocardiography and heart failure. His research focuses on body fluid status and cardio-renal interactions in patients with heart failure, exploring how electrolyte balance influences cardiac function and disease progression. Dr. Kataoka is best known for developing the groundbreaking “chloride theory” of heart failure pathophysiology, which redefines traditional perspectives by emphasizing chloride’s key role in regulating body fluid distribution and congestion, surpassing the conventional sodium-based understanding. This innovative theory has significantly influenced modern approaches to assessing diuretic response, predicting prognosis, and optimizing treatment strategies in heart failure management. With 107 published documents, 1,101 citations from 816 citing documents, and an h-index of 19, Dr. Kataoka has made a lasting impact on cardiovascular research and clinical practice. His scientific insights continue to inspire new investigations into electrolyte physiology, fluid regulation, and therapeutic innovation, solidifying his reputation as a thought leader in contemporary cardiology and as a driving force behind transformative advances in the field.

Profiles: Scopus | Orcid

Featured Publications

Kataoka, H. (2023). Acetazolamide as a potent chloride-regaining diuretic: Time to re-evaluate its diverse actions. Polish Archives of Internal Medicine.

Kataoka, H. (2022). Estimation of plasma renin activity on the basis of serum and urinary chloride concentrations versus sodium concentrations. Cardiorenal Medicine.

Kataoka, H. (2022). Mechanistic insights into chloride-related heart failure progression according to the plasma volume status. ESC Heart Failure.

Kataoka, H. (2020). Comparison of changes in plasma volume and renal function between acetazolamide and conventional diuretics: Understanding the mechanical differences according to their effects. Cardiology.

Kataoka, H., & Yoshida, Y. (2020). Enhancement of the serum chloride concentration by administration of sodium-glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: A pilot study. Diabetology & Metabolic Syndrome.

Xinke Wang | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Xinke Wang | Heart Failure | Best Researcher Award

China Medical University | China

Ms. Xinke Wang is a dedicated researcher and master’s scholar at China Medical University, specializing in cardiovascular diseases with a particular focus on heart failure. Her academic background integrates clinical and epidemiological research, emphasizing the translation of basic scientific discoveries into effective clinical applications. Through her work, she strives to elucidate novel mechanisms underlying heart failure progression and identify innovative therapeutic strategies to improve patient care and outcomes. Ms. Wang has contributed significantly to various aspects of research, including data curation, conceptualization, methodology design, software development, formal analysis, validation, and manuscript preparation. Her ability to bridge clinical insight with analytical expertise underscores her commitment to advancing cardiovascular medicine. Collaborating with esteemed institutions such as Kailuan General Hospital, she actively engages in multidisciplinary research aimed at improving diagnostic precision and treatment efficacy in heart failure management. Her growing body of work reflects both academic rigor and practical relevance, contributing to the evolving landscape of cardiovascular research. Ms. Wang’s scholarly efforts exemplify a strong dedication to medical innovation, evidence-based practice, and collaborative science. By combining her expertise in epidemiology with a passion for clinical application, she continues to advance the understanding of cardiovascular health and disease, fostering new approaches that hold promise for enhancing patient outcomes and shaping the future of cardiovascular research.

Profile: Orcid

Featured Publication

Wang, X., Ning, N., Li, Y., Huang, R., Liu, Y., Miao, Y., Zhang, W., Chen, S., Gao, J., Wu, S., et al. (2025). Association of scores on the Life’s Essential 8 scale with progression to type 2 diabetes, heart failure, and death: A multistate Markov model analysis. Maturitas.

Songwen Chen | Arrhythmia | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Songwen Chen | Arrhythmia | Best Research Article Award

Dr. Songwen Chen, Shanghai General Hospital, China

Dr. Songwen Chen is an Associate Chief Physician at Shanghai General Hospital and a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. He specializes in cardiology and electrophysiology, with extensive experience in catheter ablation for arrhythmias such as atrial fibrillation and ventricular tachycardia. Dr. Chen holds a doctorate in Internal Medicine from Shanghai Jiao Tong University and has published widely on topics including arrhythmia management, skin sympathetic nerve activity, and catheter-based interventions. He has received numerous research grants and plays a key role in educating future cardiologists. His work continues to advance both clinical practice and research in cardiology.

Profile:

Google scholar Profile

🎓 EDUCATION 

Dr. Songwen Chen’s educational background is distinguished by his dedication to the field of medicine and cardiology. He earned his Bachelor’s degree in Medicine from Soochow University, followed by a Master’s degree in Internal Medicine from Fudan University’s Zhongshan Hospital. His pursuit of advanced knowledge continued with a Doctorate in Internal Medicine from Shanghai General Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This strong academic foundation in medical science has provided Dr. Chen with the expertise needed to excel in clinical cardiology and electrophysiology, enabling him to make significant contributions to both research and patient care.

💼 PROFESSIONAL EXPERIENCE:

Dr. Songwen Chen is an Associate Chief Physician in the Department of Cardiology at Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, where he has worked since 2012. In addition to his clinical duties, which include performing electrophysiology studies and catheter ablation for arrhythmias, he also supervises graduate students as a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. Dr. Chen has contributed extensively to research, securing several prestigious grants, and publishing numerous studies on topics such as arrhythmia management, electrophysiology, and catheter-based interventions. His professional experience blends clinical practice with significant academic and research achievements.

🌍 Research experience  

Dr. Songwen Chen has extensive research experience in the field of cardiology, with a focus on electrophysiology and arrhythmia management. His work includes studying catheter ablation techniques for atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. Dr. Chen has made significant contributions to understanding the role of the inferior vena cava in triggering atrial fibrillation and exploring the relationship between skin sympathetic nerve activity and QT interval variability. He has published in prominent journals such as JACC: Clinical Electrophysiology and Pacing and Clinical Electrophysiology. His research is supported by prestigious grants and has led to innovative advancements in clinical cardiology.

🏅Award And Honors

Dr. Songwen Chen has received several prestigious awards and honors throughout his career, reflecting his exceptional contributions to the field of cardiology. His groundbreaking research has been recognized with grants from prominent organizations such as the National Natural Science Foundation of China and the Shanghai Municipal Commission of Health and Family Planning. Additionally, his innovative work in electrophysiology and catheter ablation for arrhythmias has earned him widespread recognition within the medical community. Dr. Chen’s academic excellence, clinical expertise, and dedication to advancing cardiology make him a highly respected figure, deserving of continued recognition and accolades in his field.

Citations:

Citations – 914
h-index1 – 71
i10-index – 27

Conclusion:

Dr. Songwen Chen stands as a distinguished figure in cardiology, merging clinical expertise with impactful research and education. His dedication to advancing electrophysiology, combined with his leadership at Shanghai General Hospital and Shanghai Jiao Tong University School of Medicine, underscores his commitment to improving cardiovascular health outcomes. Dr. Chen’s work not only elevates patient care but also inspires the next generation of medical professionals, solidifying his legacy in the field of cardiology.

TOP NOTABLE PUBLICATIONS:

Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b
Authors: L Cai, B Qi, X Wu, S Peng, G Zhou, Y Wei, J Xu, S Chen, S Liu
Journal: Journal of Molecular and Cellular Cardiology
Year: 2019

Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis
Authors: X Li, JSK Chan, B Guan, S Peng, X Wu, X Lu, J Zhou, JMH Hui, YHA Lee, …
Journal: Cardiovascular diabetology
Year: 2022

Activated CD4+ T cells-derived exosomal miR-142-3p boosts post-ischemic ventricular remodeling by activating myofibroblast
Authors: L Cai, G Chao, W Li, J Zhu, F Li, B Qi, Y Wei, S Chen, G Zhou, X Lu, J Xu, …
Journal: Aging (Albany NY)
Year: 2020

Micro RNA‐30c suppresses the pro‐fibrogenic effects of cardiac fibroblasts induced by TGF‐β1 and prevents atrial fibrosis by targeting TGF β RII
Authors: J Xu, H Wu, S Chen, B Qi, G Zhou, L Cai, L Zhao, Y Wei, S Liu
Journal: Journal of Cellular and Molecular Medicine
Year: 2018

Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility
Authors: B Qi, Y Wei, S Chen, G Zhou, H Li, J Xu, Y Ding, X Lu, L Zhao, F Zhang, …
Journal: Cardiovascular research
Year: 2014

LCZ696 ameliorates oxidative stress and pressure overload‐induced pathological cardiac remodeling by regulating the Sirt3/MnSOD pathway
Authors: S Peng, X Lu, Y Qi, J Li, J Xu, T Yuan, X Wu, Y Ding, W Li, G Zhou, Y Wei, …
Journal: Oxidative Medicine and Cellular Longevity
Year: 2020

Blocking the pulmonary vein to left atrium conduction in addition to the entrance block enhances clinical efficacy in atrial fibrillation ablation
Authors: S Chen, W Meng, D Sheng He, G Chen, F Zhang, Y Yan, Y Zhu-Ge, …
Journal: Pacing and Clinical Electrophysiology
Year: 2012

Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: an in vivo approach
Authors: W Li, S Chen, G Zhou, H Li, L Zhong, S Liu
Journal: Saudi Journal of Biological Sciences
Year: 2018

Procedural arrhythmia termination and long‐term single‐procedure clinical outcome in patients with non‐paroxysmal atrial fibrillation
Authors: G Zhou, S Chen, G Chen, F Zhang, W Meng, Y Yan, X Lu, Y Wei, S Liu
Journal: Journal of Cardiovascular Electrophysiology
Year: 2013

Age-and sex-related difference in lipid profiles of patients hospitalized with acute myocardial infarction in East China
Authors: Y Wei, B Qi, J Xu, G Zhou, S Chen, P Ouyang, S Liu
Journal: Journal of Clinical Lipidology
Year: 2014